OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OPKO Health (NASDAQ: OPK) will report its second-quarter 2026 operating and financial results on Monday, July 27, 2026. Senior management will host a conference call and webcast at 4:30 p.m. ET, with live access via pre-registration or dial-in and replays available through early August 2026.
Details
News Market Reaction – OPK
On Jul 23, the day this news came out, OPK closed 0.85% below the previous close. Our momentum scanner recorded 3 alerts in the available session data.
Data tracked by StockTitan Argus for the Jul 23 session.
Key Figures
- Results Reporting Date
- July 27, 2026
- Second-quarter 2026 operating and financial results
Previous Earnings date Reports
-
Announced Q1 2026 results date and management conference call timing
-
Announced Q4 2025 results date and financial guidance discussion
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using this link. Participants who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed through OPKO’s Investor Relations here.
A telephone replay will be available until August 3, 2026, by dialing 855-669-9658 (U.S.) or 412-317-0088 (International) and providing the passcode 6858214. A webcast replay will be available beginning approximately one hour after the completion of the live conference call through OPKO’s Investor Relations here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Vivian Cervantes, 973-873-7724
vcervantes@allianceadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.